4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-24-038438
Chief Executive Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gibson Christopher · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 1 in the form | +5,000 | $2.48 | $12,400 | 742,656 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −5,000 | 302,500 | D |
Loading xslF345X05/wk-form4_1724704942.xml…